70%Confidence
0Views
FDASource
2026-04-12Date
Summary
Annora Pharma's Class III recall for Pitavastatin tablets due to incorrect tablet mixing represents a packaging error that, while lower risk, suggests quality control failures in its Indian manufacturing facility. This could lead Northstar Rx to reconsider its supplier relationship and seek more reliable manufacturing partners.
Actionable: Monitor Northstar Rx's response to this recall and any potential shifts in its generic drug sourcing strategy away from Annora Pharma.
AI Confidence: 70%
Data Points
firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now